相关实验视频

Updated: Sep 17, 2025

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

在孤立的人类心房准备剂中,雷塔鲁的内热效应

Joachim Neumann¹, Undine Ahlrep², Britt Hofmann³

¹Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097, Halle (Saale), Germany. joachim.neumann@medizin.uni-halle.de.

Naunyn-Schmiedeberg's archives of pharmacology

|July 4, 2025

概括

发现糖尿病和肥胖症的新型药物雷塔鲁提德在人类心房准备剂中增加了心脏收缩力. 这些效应通过多个受体和cAMP信号通路进行介导.

科学领域:

药理学药理学是指药理学的学科.
心脏病学心脏病学
内分泌学在内分泌学.

背景情况:

雷塔胺是一种新型类药物,用于治疗2型糖尿病和肥胖症.
它向葡萄糖受体 (GCGR),依赖葡萄糖的胰岛素型多受体 (GIPR) 和类似葡萄糖-1受体 (GLP-1R).
雷塔鲁提德增加了腺环酶活性和循环腺单酸盐 (cAMP) 水平.

研究的目的:

在人类右心房准备剂 (HAP) 中,研究复原对收缩力 (FOC) 的影响.

主要方法:

使用了来自冠心病的成年患者的人类右心房准备剂 (HAP).
雷塔鲁提德在从10nM到100nM的度下累积应用.
评估了与其他药物 (包括受体对抗剂和信号抑制剂) 以及没有其他药物的对FOC的影响.

主要成果:

雷他胺显著增加了HAP中的FOC,以一种依赖于度和时间的方式.
这种药物在存在固酶III抑制剂的情况下增强了功效和疗效,并缩短了放松时间.
这些效应是由GLP1-R,GIPR和GCGR调解的,涉及cAMP系统和氨酸受体,但不涉及β-氨酸受体.

结论:

雷塔鲁提德对人类心房准备剂产生积极的内效应.
该机制涉及刺激GCGR,GIPR和GLP-1R,导致cAMP水平增加.
雷塔鲁提德对心脏收缩性的影响需要在治疗用途的背景下进一步研究.

关键词:

在GIP的基础上,GIP是GIP.这就是GLP-1.葡萄糖受体的受体是什么人类心房是人的心房.鼠标的心房是什么意思利塔特鲁提德 (Retatrutide) 是一种复原剂.

更多相关视频

Simultaneous Isolation and Culture of Atrial Myocytes, Ventricular Myocytes, and Non-Myocytes from an Adult Mouse Heart

Simultaneous Isolation and Culture of Atrial Myocytes, Ventricular Myocytes, and Non-Myocytes from an Adult Mouse Heart

Published on: June 14, 2020

Isolation of Atrial Myocytes from Adult Mice

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

相关概念视频

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...